tirzepatide and bruising & Zepbound Rash Injection-Site Reactions: Causes, Treatment, and Prevention Injection Site Reaction Tirzepatide: Causes,

Our approach combines medical treatment with practical strategies you can maintain long-term

- () () ,

A Cureus review of the Oral Semaglutide in Adults with Overweight or Obesity (OASIS) trials reported that oncedaily oral semaglutide 50 mg cut body weight by a mean 15.1 percent versus 2.4 percent with placebo in OASIS 1 over 68 weeks, 14.3 percent versus 1.3 percent in OASIS 2, and 13.6 percent versus 2.2 percent in OASIS 4, all with highly significant p values

Treatment with pioglitazone is a logical approach in patients with histologically proven NASH

The cardiovascular evidence gap matters in two directions: it is a hard advantage for semaglutide on documented benefit, and an unknown for retatrutide that the glucagon-receptor arm makes worth watching specifically (glucagon-agonist effects on heart rate and metabolic rate are documented but the long-term MACE signal is open)